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Abstract 
Background. Attentional impairment is a core cognitive feature of major depressive disorder (MDD) and 
bipolar disorder (BD). However, little is known of the characteristics of response time (RT) distributions 
from attentional tasks. This is crucial to furthering our understanding of the profile and extent of 
cognitive intra-individual variability (IIV) in mood disorders. 
Method. A computerised sustained attention task was administered to 138 healthy controls and 158 
patients with a mood disorder: 86 euthymic BD, 33 depressed BD and 39 medication-free MDD patients. 
Measures of IIV, including individual standard deviation (iSD) and coefficient of variation (CoV), were 
derived for each participant. Ex-Gaussian (and Vincentile) analyses were used to characterise the RT 
distributions into three components: mu and sigma (mean and standard deviation of the Gaussian 
portion of the distribution) and tau (the ‘slow tail’ of the distribution). 
Results. Compared to healthy controls, iSD was increased significantly in all patient samples. Due to 
minimal changes in average RT, CoV was only increased significantly in BD depressed patients. Ex-
Gaussian modelling indicated a significant increase in tau in euthymic BD (Cohen’s d=0.39,95%CI=0.09-
0.69;p=0.011), and both sigma (d=0.57,95%CI=0.07-1.05;p=0.025) and tau (d=1.14,95%CI=0.60-
1.64;p<0.00001) in depressed BD. The mu parameter did not differ from controls.  
Conclusions. Increased cognitive variability may be a core feature of mood disorders. This is the first 
demonstration of differences in attentional RT distribution parameters between MDD and BD, and BD 
depression and euthymia. These data highlight the utility of applying measures of IIV to characterise 
neurocognitive variability and the great potential for future application.  
 
Key words: neuropsychology; attention; variability; ex-Gaussian; bipolar disorder; major depression.  
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Introduction 
Neurocognitive dysfunction is a common feature of mood disorders. Deficits in a range of cognitive 
processes have been described during symptomatic episodes in major depressive disorder (MDD) 
(Zakzanis et al. 1998; Lee et al. 2012; Rock et al. 2014) and bipolar disorder (BD) (Rubinsztein et al. 2006; 
Kurtz & Gerraty 2009; Gallagher et al. 2014; Gallagher et al. 2015), including in medication-free patients 
(Porter et al. 2003; Taylor Tavares et al. 2007). There has long been an emphasis on the extent to which 
such deficits can be observed in clinical remission (Astrup et al. 1959; Bratfos & Haug 1968), with 
growing consensus that they may be state-independent (Robinson et al. 2006; Torres et al. 2007; Arts et 
al. 2008; Bora et al. 2012; Bourne et al. 2013). The further identification – albeit less consistently – of 
modest dysfunction in the non-affected, first-degree relatives of affected probands (Balanzá-Martínez et 
al. 2008; Bora et al. 2009) has resulted in some aspects of neurocognitive dysfunction being put forward 
as candidate cognitive endophenotypes for mood disorders. Due to a paucity of studies in some areas, 
there remains debate over the extent to which specific cognitive deficits can be viewed as true 
endophenotypes (i.e. heritable, co-segregating, and found in non-affected family members at a higher 
rate than in the general population; Gottesman & Gould 2003) rather than core illness ‘traits’, emerging 
consequent to the mood disorder (Glahn et al. 2004; Christensen et al. 2006; Daban et al. 2012).  
 
Impairments in facets of attentional processing have been described in many studies of neurocognitive 
function in mood disorders (Cohen et al. 2001). Deficits have been observed in MDD and BD patients 
when euthymic (Paelecke-Habermann et al. 2005; Torrent et al. 2006; Preiss et al. 2009; Robinson et al. 
2013) as well as abnormalities in the activation of underlying neurocircuitry when performing attentional 
tasks (Strakowski et al. 2004; Mullin et al. 2012). Following the observation of deficits in first-degree 
relatives of BD patients, and euthymic recurrent MDD patients, attentional control (cognitive flexibility) 
has been suggested as candidate endophenotype for mood disorder in general (but not actual disease 
phenotypes) (Clark et al. 2005b). One of the most frequently examined aspects of attention in mood 
disorders has been vigilance (or sustained attention). Performance decrements, which increase with 
time-on-task, on the degraded stimulus form of the continuous performance test (CPT) in euthymic BD 
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patients have led to the suggestion that alterations in sustained attention may be an endophenotype for 
BD (Ancín et al. 2010). Numerous other studies have demonstrated CPT deficits in BD and MDD in 
symptomatic states (Koetsier et al. 2002; Porter et al. 2003; Fleck et al. 2012; Gallagher et al. 2014) and 
in euthymia (Wilder-Willis et al. 2001; Liu et al. 2002; Weiland-Fiedler et al. 2004; Doyle et al. 2005; 
Thompson et al. 2005; Kolur et al. 2006). CPT deficits have also been observed in some (Klimes-Dougan 
et al. 2006; Trivedi et al. 2008) but not all (Clark et al. 2005a; Meyer & Blechert 2005; Jabben et al. 2009; 
Walshe et al. 2012) studies in first-degree relatives. A recent study found both behavioural deficits and 
functional magnetic resonance imaging (fMRI) differences (increased activation in the insula and parts of 
the cingulate cortex) during a CPT in euthymic BD-I patients and non-affected relatives compared to 
controls (Sepede et al. 2012).  
 
One important consideration in the assessment of attentional processes is in the method of performance 
measurement. In most CPTs, absolute errors, signal detection indices or mean reaction time (RT) over 
sub-components or the overall task are typically used. However, increasingly there is recognition of the 
need to go beyond such measures and take into account inconsistency of responses or intra-individual 
variability (IIV). This can be achieved most simply by calculation of the standard deviation of item-by-
item RT for each individual (or the individual standard deviation; iSD), although as this measure is 
strongly related to mean RT, the coefficient of variation (CoV) is often preferred (Jackson et al. 2012) 
which divides the iSD by the corresponding individual’s mean RT. Such measures are being increasingly 
applied in the cognitive ageing literature (Nilsson et al. 2014), where it has been reported that IIV indices 
are better than mean RT in differentiating early neurodegeneration from healthy aging (Hultsch et al. 
2002), and are strongly related to broader cognitive function (Bielak et al. 2010) and brain white matter 
integrity (Fjell et al. 2011; Jackson et al. 2012). However, empirical RT distributions are fundamentally 
non-normal and tend to be positively skewed and there is growing interest in the utility of mathematical 
RT modelling to characterise dissociable components of RT distributions (Balota & Yap 2011).  
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The ex-Gaussian distribution, a mathematical convolution of a Gaussian (normal) and exponential 
distribution, produces a good approximation to empirical RT distributions (Schmiedek et al. 2007). The 
ex-Gaussian distribution has three parameters: mu and sigma, the mean and standard deviation of the 
Gaussian (normal) component; and tau, which determines the exponential component and represents 
the relative strength of the ‘slow-tail’ of the distribution (Ratcliff 1979). As the ex-Gaussian model 
represents the distribution of RT, it can intuitively be related to ‘standard’ arithmetic properties, for 
example, the sum of mu and tau equals the overall arithmetic mean of the data (Ratcliff 1979; Heathcote 
et al. 1991). This methodology has been used to model RT in a number of attentional tasks in older 
adults, for example, demonstrating a clear increase in the tau component in mild dementia of the 
Alzheimer's-type compared to controls, which correlated with decreased cerebral white matter (Tse et 
al. 2010; Jackson et al. 2012). More generally, RT variability has been linked to white matter integrity 
across the normal developmental trajectory in healthy children, adolescents and adults: maturation of 
white matter integrity and connectivity leading to reductions in RT IIV (Fjell et al. 2011; Tamnes et al. 
2012). Given the growing evidence of impaired white matter integrity in MDD and BD and those at high-
risk (Heng et al. 2010; Macritchie et al. 2010; Sprooten et al. 2011; Henderson et al. 2013; Leow et al. 
2013; Sarrazin et al. 2014; Wang et al. 2014) there is a clear rationale for applying such analyses to 
attentional RT data in mood disorder. 
 
Despite the potential utility of these approaches, there is very little data on IIV in mood disorders. 
Increased variability on the Connors CPT in manic and euthymic patients has been reported (Bora et al. 
2006), although variability was examined between average blocks of trials rather than individual RT. One 
study found a large effect size in the increase in RT iSD from a CPT in young BD probands and their 
unaffected first-degree relatives compared to matched controls (Brotman et al. 2009). It has been 
reported that RT iSD from a Go/No-go paradigm was increased in patients with 
schizophrenia/schizoaffective disorder, but not in those with major depression or borderline personality 
disorder compared to healthy controls (Kaiser et al. 2008). To date there has been no comprehensive 
assessment of attentional IIV, with full RT modelling, in mood disorders.  
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The aim of the present study was therefore to examine RT distributions from an attentional CPT in 
patients with mood disorders, comparing iSD, CoV and ex-Gaussian components (mu, sigma and tau) in 
patients with bipolar disorder (euthymia and depression), medication-free depression and healthy 
control participants. As the ex-Gaussian is a parametric model of an underlying theoretical distribution, 
Vincentile analysis was also conducted in order to demonstrate convergence across the two techniques 
(Tse et al. 2010). This non-parametric technique directly assesses raw empirical RT distributions and 
makes no assumptions about an underlying theoretical distribution (by first ordering and then dividing 
the empirical distribution into a number of equal-sized ‘bins’ and computing the average RT in each of 
these bins). It was hypothesised that, overall, the mood disorder groups would show a significantly 
increased IIV and ex-Gaussian tau component (reflecting increased response variability, especially 
slowing) compared to matched controls.  
 
Methods and Materials 
Individual RT datasets were collated from multiple studies conducted in the Institute of Neuroscience 
(Academic Psychiatry), Newcastle University which had used the same attentional task (Porter et al. 
2003; Thompson et al. 2005; Macritchie et al. 2010; Gallagher et al. 2014). 
Participants 
Patients aged 18 to 65 years with a diagnosis of bipolar disorder (BD) confirmed using the Structured 
Clinical Interview for DSM-IV (SCID; First et al. 1995), were recruited from secondary and tertiary care 
services in North East of England. All were out-patients and either currently in a depressive episode (SCID 
defined) or euthymic, prospectively defined as ≤7 on both the Hamilton Depression Rating Scale 
(HDRS21; Hamilton 1960) and the Young Mania Rating Scale (YMRS; Young et al. 1978) at initial 
assessment and after 1 month. Patients were excluded if they met criteria for any other current Axis I 
disorder (except anxiety) or substance dependence/abuse. All were receiving medication at the time of 
testing but this had remained stable for ≥4 weeks. For the MDD cohort, patients aged 18 to 65 years with 
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a DSM–IV diagnosis of major depressive disorder (MDD), single episode or recurrent, were recruited 
from general practice clinics. For this latter (MDD) cohort, patients had been entirely psychotropic 
medication-free for at least 6 weeks before recruitment and were excluded if currently taking other 
medication active in the central nervous system, including beta-blockers or St. John’s Wort, or if there 
was a comorbid medical/psychiatric diagnosis, or recent alcohol/substance misuse. All were tested as 
soon as possible after recruitment to minimise delay in treatment. For all participants, illness 
characteristics, clinical ratings and medication history were determined by trained psychiatrists using full 
history, case-note and medication review and standardized rating scales. All studies were approved by 
the local NHS Research Ethics Committee and all participants gave written, informed consent. 
Neurocognitive testing 
All participants completed the Vigil continuous performance test (Cegalis & Bowlin 1991) using the same 
parameters. In this task, a continuous stream of random letters of the English alphabet is displayed on a 
computer screen. Each letter appears for 85ms, followed by a 900ms inter-stimulus interval (ISI) and is 
presented as a white letter on a black background in the centre of the screen (see Figure 1). Participants 
are instructed to look out for a target sequence (an ‘A’ immediately followed by a ‘K’) and must respond 
“as quickly, but as accurately as possible” by pressing the spacebar if this target sequence occurs. The 
letter ‘A’ thereby becomes the signal for the potential occurrence of a target sequence, but responses 
should only be made once the second letter of the sequence, ‘K’, appears. In total, 480 letters are 
displayed, in which 100 target sequences occur. These are pseudo-randomised between each quarter of 
the test i.e. so there are 25 targets within every 120 trials (The Psychological Corporation 1998).  
 
Data analysis procedure 
Data extraction and cleaning 
RT data were re-extracted from the original Vigil CPT output files and any responses were either 
classified as ‘valid’ or as ‘commission error’ according to their temporal relationship to the target 
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sequence1. Response times were always measured in relation to the onset of the second stimulus of a 
target sequence (letter ‘K’). In contrast to the standard analysis, we classified responses as ‘valid’ even if 
they occurred after the onset of the letter that immediately followed a target sequence (see Figure 1), 
allowing maximum response times of up to 1970ms (i.e. [2 x ISI] + [2 x letter duration]). However, there 
is one exception to this rule: since it is possible that two (or more) target sequences follow directly after 
another (i.e. ‘A-K-A-K’), responses to the second ‘A’ would no longer be considered valid for the initial 
target sequence, as such a response could be a premature response to the new target sequence. Such 
responses were classified as commission errors. Any other responses that could not be associated with a 
target stimulus according to the above rules were also classified as commission errors. Target stimuli 
with no detectable valid response were classified as ‘misses’.  
 
Insert figure 1 about here 
This classification scheme ensured that responses with RT just above the ISI were considered (late) valid 
responses to the target, instead of resulting, according to the original scheme, in a “miss” classification 
to the target stimulus and a commission error for the stimulus following the target. While we believe 
that this classification better reflects the underlying psychological processes, it is important to consider 
the number of misses when looking at the distribution of response times of an individual. For instance, 
some individuals may have been better able than others to withhold responses when they detected that 
those responses would be late (i.e. after the onset of the stimulus following a target), thereby restricting 
their maximum response times to the “standard” response window. Since such behaviour would reduce 
the potential range of RTs and therefore RT variability, care must be taken that this reduction does not 
come at a cost of an increased number of misses. 
 
                                                          
1 this was done to permit the analysis of RT in relation to the intended target, independent of ISI. In typical analysis of 
continuous attention tasks, the RT is limited to a maximum ≤ ISI ms. For example, if a participant is slow to recognise given 
target sequences and make a response, even though their responses may be initiated validly by targets, they will be incorrectly 
recorded as errors if a subsequent letter is presented before their response can be completed. Most often these will appear as 
very fast commission errors. 
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IIV analysis and ex-Gaussian modelling 
From valid responses, basic measures of IIV were derived using the iSD – the SD of all RT for each 
individual, and the CoV – the iSD divided by an individual’s mean RT. Ex-Gaussian probability density 
functions were fitted to the distribution of valid response times of each individual using the DISTRIB 
toolbox (Lacouture & Cousineau 2008) in MATLAB® v.R2010b (The MathWorks Inc. 2010). This toolbox 
uses maximum likelihood principles to estimate the ex-Gaussian distribution parameters mu, sigma and 
tau. Vincentile plots were also derived as a distribution-free representation of the data. For these data, 
RTs within each participant were ranked and eight Vincentiles derived (representing the average RT 
within each sequential 12.5% of valid data, from fastest to slowest). Individual Vincentiles were then 
averaged across participants.  
 
Healthy control reference data 
An SAS algorithm was used (Kosanke & Bergstralh 1995) which sampled from the overall control cohort 
(n=138) and matched controls to individual cases according to age, sex and NART estimated IQ (Nelson 
1982). This created very closely matched healthy control groups for each of the three patient groups. 
Group analyses were made using SPSS v19.  
 
Results 
Subject demographics and clinical details  
In total 297 datasets were available for analysis (see table 1). This included 138 healthy controls (61 
males, 77 females) and 159 patients. The three patient samples included: 86 euthymic bipolar patients 
(41 males, 45 females), 33 depressed bipolar patients (19 males, 14 females) and 39 depressed MDD 
patients (15 males, 24 females). Data from one further female depressed MDD patient were excluded 
from the analysis as only 22% valid responses were recorded for this patient. The three patient groups 
and their respective matched control groups were closely matched for age and NART-estimated IQ 
(p>0.69 for all). 
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None of the patients in the MDD group were currently on psychotropic medication. Twenty four (62%) 
had never previously taken antidepressant medication; of the remaining 15 (38%), the median time since 
last treatment was 12 months (range 2-84 months). Five bipolar patients were drug-free at the time of 
testing. In the euthymic sample, n=76 (88%) were taking a mood stabiliser (of which n=55 lithium), n=23 
(27%) antidepressant medication, and n=23 (27%) antipsychotic medication. In the depressed sample, 
n=27 (84%) were taking a mood stabiliser (of which n=8 lithium), n=26 (81%) antidepressant medication, 
and n=15 (47%) an antipsychotic medication. Medication details of one patient were not recorded.  
 
Response profiles  
Within the original raw dataset (n=296), a total of 29,677 individual trials were recorded, of which 28,482 
(96.0%) were responses within the originally defined response window (0-985ms). The remaining 4.0% 
were classified as: early (300/29,677; 1.0%), i.e. responses that occurred before the “K” of an “AK” target 
sequence; or late (201/29,677; 0.7%) i.e. ‘correct’ responses which were slow (985-1970ms)2; or misses 
(694/29,677; 2.3%). Examining these between patients and controls indicated that the greater 
proportion of early (226/300; 75.3%) and late responses (152/201; 75.6%), and misses (570/694; 82.1%) 
occurred in the patient sample. Comparing these directly revealed that, on average, significantly more 
misses occurred in all 3 patient samples compared to their respective control group, with depressed BD 
patients also making more early and late responses (see table 2). 
 
Following data cleaning (see methods above), an average of 94.4 (SD=8.14) responses per participant in 
patients and 98.3 (SD=3.11) responses per participant in controls were available for RT analysis.  
 
 
                                                          
2 As this method of classification recoded the majority of what would previously have been considered ‘commission errors’ into 
‘correct-late’ responses, in the present analysis commission errors were very infrequent and not considered further. 
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Average RT 
The analysis of the standard average RT showed significantly slower RT for the group of euthymic BD 
patients (F1,170=6.322, p=0.013; d=0.38, 95%CI=0.08 to 0.68; see Table 2), but not for the group of 
depressed BD patients (F1,64=1.009, p=0.319; d=0.25, 95%CI=-0.24 to 0.73) or the group of depressed 
MDD patients (F1,76=0.048, p=0.826; d=0.05, 95%CI=-0.39 to 0.49) compared to controls.  
 
IIV indices 
The various measures of intraindividual RT variability are shown in Table 2. Analysis of the iSD 
demonstrated significantly greater variability in patients compared to their matched control data, for 
euthymic BD (F1,170=4.785, p=0.030; d=0.33, 95%CI=0.03 to 0.63), depressed BD (F1,64=32.474, p<0.00001; 
d=1.40, 95%CI=0.85 to 1.92) and depressed MDD (F1,76=5.662, p=0.020; d=0.54, 95%CI=0.08 to 0.99). 
Accounting for the overall mean RT, a significantly greater CoV was observed in depressed BD 
(F1,64=28.824, p<0.00001; d=1.32, 95%CI=0.77 to 1.84). There was also a statistical trend for greater CoV 
for depressed MDD (F1,76=3.545, p=0.064; d=0.43, 95%CI=-0.02 to 0.87), but no difference in euthymic BD 
(F1,170=0.732, p=0.393; d=0.13, 95%CI=-0.17 to 0.43).  
 
Ex-Gaussian analysis and Vincentile Plots 
The ex-Gaussian analysis indicated that there were differences across the 3 distribution parameters (see 
table 2). No significant differences between patients and controls were observed in mu (euthymic BD: 
F1,170=1.943, p=0.165; d=0.21, 95%CI=-0.09 to 0.51; depressed BD: F1,64=1.864, p=0.177; d=-0.34, 95%CI=-
0.82 to 0.15; depressed MDD: F1,76=0.301, p=0.585; d=-0.12, 95%CI=-0.57 to 0.32). No significant 
differences in the sigma parameter were observed for euthymic BD (F1,170=1.918, p=0.168; d=0.21, 
95%CI=-0.09 to 0.51) or depressed MDD (F1,76=1.901, p=0.172; d=0.31, 95%CI=-0.14 to 0.76), but sigma 
was significantly increased in depressed BD (F1,64=5.292, p=0.025; d=0.57, 95%CI=0.07 to 1.05). A 
significant increase in the exponential part of the RT distribution was observed for both BD patient 
groups: the tau parameter was greater in euthymic BD (F1,170=6.604, p=0.011; d=0.39, 95%CI=0.09 to 
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0.69) and depressed BD (F1,64=21.347, p<0.0001; d=1.14, 95%CI=0.60 to 1.64) compared to controls. 
There was also a statistical trend for greater tau in depressed MDD (F1,76=3.034, p=0.086; d=0.39, 
95%CI=-0.06 to 0.84).  
 
Vincentile plots are shown in figure 2, providing convergent support for the ex-Gaussian analyses. For 
the euthymic BD sample, the plots for patients are controls remain close until the last Vincentile (V8) 
where they diverge more sharply. This occurs more clearly in the depressed MDD and BD samples, 
particularly the latter. However, there are also differences evident in the first Vincentile (V1) for the 
depressed samples, with responses being faster in patients than controls (a difference which is 
significant in the BD depressed sample (p=0.024). 
 
To facilitate comparison between patient groups, the ex-Gaussian parameters for euthymic BD, 
depressed BD and MDD groups were expressed as a z-score based on the mean and SD of their 
respective control groups. One-way ANOVA revealed significant differences for mu (F2,155=4.348, 
p=0.015) and tau (F2,155=15.545, p<0.0001). Post hoc contrasts revealed that the mu parameter was 
significantly different between euthymic and depressed BD groups (p=0.006) with a trend between 
euthymic BD and MDD groups (p=0.085). For tau, the depressed BD group differed significantly from 
both euthymic and MDD groups (p<0.001) (see table 2 for data).  
 
Receiver Operating Characteristic (ROC) analysis 
To demonstrate the degree of differentiation between the clinical groups and controls (i.e. that 
differences are not consequent to extreme responses from a small number of participants), an ROC plot 
(Wilcoxon estimate) was used to determine the optimum cut-point to maximise sensitivity and 
specificity. For MDD, a tau value of 56.12 yielded a ROC AUC=0.60 (95%CI=0.46 to 0.73), with 
sensitivity=0.74 and specificity=0.44. For euthymic BD, a tau value of 56.35 yielded a ROC AUC=0.62 
(95%CI=0.53 to 0.70), with sensitivity=0.77 and specificity=0.44. For depressed BD, a tau value of 85.56 
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yielded a ROC AUC=0.82 (95%CI=0.70 to 0.93), with sensitivity=0.73 and specificity=0.88. Comparing 
between the clinical groups, the tau parameter also differentiated depressed from euthymic BD patients 
with sensitivity=0.70 and specificity=0.71 (ROC AUC=0.73, 95%CI=0.61 to 0.84), and depressed BD from 
depressed MDD with sensitivity=0.73 and specificity=0.65 (ROC AUC=0.68, 95%CI=0.55 to 0.82). 
 
Relationship to severity of depression 
Exploratory Spearman’s correlations were performed separately for each patient group, between IIV 
parameters and the HDRS21. No significant correlations between iSD, CoV or ex-Gaussian parameters 
were observed in euthymic (-0.073≤rs ≤0.188, p>0.080 for all) or depressed BD (-0.135≤rs≤-0.017, p>0.450 
for all). For MDD patients, a near-significant positive correlation between depression severity and CoV 
was observed (r=0.314, p=0.051).  
 
Discussion 
The present study investigated intra-individual RT variability during a simple sustained attention task in 
three groups of patients with mood disorders, euthymic BD, depressed BD and depressed MDD. All three 
groups showed evidence of increased response variability compared to matched controls. Euthymic BD 
patients had greater values of iSD and tau, but not in CoV or sigma. Together with the fact that this 
group also showed greater standard average RT, but not in the fitted mu parameter, these results 
indicate that the differences between these patients and controls is best characterized as in increase in 
the exponential part of the RT distribution (i.e. an increased number of ‘disproportionately slow’ 
responses), as this would cause a shift in mean RT and iSD but not in CoV. Depressed BD patients showed 
the most consistent evidence of increase in RT variability, as all four indices of variability (iSD, CoV, sigma 
and tau) were significantly increased in comparison to the healthy control sample. It may at first seem 
surprising that there was no significant increase in average RT in this group as a result of increased 
variability. However, as can be seen in the Vincentile plot of this group, the increase in variability was 
due not only to an increase in the number of slow responses (similar to euthymia), but also the number 
 14 
 
of fast responses (although not to a sufficient extent to alter mu). Depressed MDD patients showed the 
weakest evidence for a RT variability increase. While the iSD was significantly higher in this group, both 
the CoV and the tau parameter showed only statistical trends for larger values. There were no 
differences in average RT, mu or sigma.  
 
These data are in line with previous reports of increased IIV in attentional performance in BD (Bora et al. 
2006; Brotman et al. 2009). However, to our knowledge this is the first paper to comprehensively 
examine RT distribution parameters and IIV across patients with mood disorders. Previous studies have 
applied ex-Gaussian RT modelling to tasks in children and adolescents with ADHD. The tau parameter has 
been suggested to produce excellent differentiation between ADHD and controls (Leth-Steensen et al. 
2000). Subsequent findings suggest that there are differences in all three parameters compared to 
controls, with more variability (sigma) and increases in mu and particularly slow (tau) responses – the 
latter suggested to reflect attentional lapses in some but not all trials (Hervey et al. 2006). In the present 
study, while there was no significant difference in mu between patients and controls, the Vincentile plots 
did indicate some evidence of faster responses in V1 in the depressed samples (which was significant in 
BD depression). There was also a significant increase in the number of misses in all patient groups (and 
early and late responses, in depressed BD), compared to controls. This general inconsistency combined 
with the frequency of disproportionately slow responses is again consistent with ‘phasic’ attentional task 
engagement/disengagement. This has been suggested previously during CPT task performance in 
euthymic BD (Robinson et al. 2013). Functional imaging has further revealed that while prefrontal 
activation occurs early during CPT performance in mania, it cannot be maintained over sustained periods 
(Fleck et al. 2012).  
 
An area of ongoing debate is the extent to which RT distribution characteristics can be linked to specific 
aspects of neurocognitive function. For example, the utility of ex-Gaussian modelling has been 
demonstrated across different conditions of the classic Stroop test, revealing attentional shifts which 
would otherwise be missed with outcomes based on simple central tendency (Heathcote et al. 1991). 
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These authors suggest that no direct attribution can be made between ‘parameter and process’ and 
while “the ex-Gaussian model describes RT data successfully, it does so without the benefit of an 
underlying theory” (Heathcote et al. 1991). However, more recently it has been proposed that the tau 
parameter is strongly related to ‘higher’ cognitive functions (a statistical composite measure of working 
memory tasks and reasoning) and is therefore a marker of individual differences in attentional/executive 
control (Schmiedek et al. 2007). As work in this area progresses – and if IIV and ex-Gaussian measures 
are applied more frequently in clinical studies –  it may be possible to derive more precise theoretical 
accounts, informing our understanding of neurocognition in mood disorders.  
 
A strength of the present study was the assessment of IIV and application of RT modelling to one single 
attentional CPT which had been used consistently in a series of studies in the same research centre. 
However, it should be noted that in addition to attention, other cognitive processes such as processing 
speed have been assessed as putative cognitive endophenotypes in BD (Antila et al. 2011; Daban et al. 
2012). One caveat is that most studies have used the Digit-Symbol task as an index of processing speed, 
but this measure is known to involve multiple interacting lower-level and higher-level cognitive control 
processes, including executive control and attention (Cepeda et al. 2013). Therefore when utilising such 
tasks in the search for candidate endophenotypes, especially if proposing process-specificity, it is 
necessary to consider more precisely the cognitive processes underpinning performance on any given 
measure. It is also important to ascertain whether IIV and shifts in the RT distribution in mood disorders 
are sensitive to the demand characteristics of tasks, such as rate of presentation or cognitive load, and 
therefore whether they are related more to impairments in attentional control or basic processing 
efficiency.  
 
Other methodological considerations should be highlighted. The present study utilised a large normative 
reference sample from which control data was selected by computer algorithm and demographically-
matched to individual patient cases. This ensured very close group-wise matching of patients and 
controls which was independent of experimenter selection. The majority of BD patients in the present 
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study were taking psychotropic medication at the time of testing. While several studies have reported 
minimal effects of medication on performance (Goswami et al. 2009; Bourne et al. 2013), the potential 
impact of medication on performance should be considered and replication in medication-free samples 
or in cohorts large enough to perform sub-group analysis is needed. The depressed MDD sample in the 
present study was entirely psychotropic medication-free at the time of testing and some evidence of 
increased IIV was observed, specifically iSD, but the ex-Gaussian parameters were not significantly 
different from controls (although tau was increased at a trend level, with a small-medium effect size). 
Differences in clinical characteristics (see Porter et al. 2003), such as medication, age (the MDD patients 
were younger) and number of episodes (the majority of MDD patients being first-episode) mean that 
comparisons need to be interpreted cautiously. Similarly the inherent difficulty in how to equate stage of 
illness and other clinical characteristics between MDD and BD in order to reliably compare them should 
also be noted, along with the issue of statistical power in relation to the sample size characteristics.  
 
The clearest comparison between IIV parameters can be made between the BD groups. It is of note that 
variability is evident in euthymia (as increased iSD and tau) but increases in depression, reflected in the 
additional increase in CoV and sigma. It would be of interest for future studies to explore the potential 
neurobiological mechanisms underlying such effects. For example, it has been demonstrated in animal 
and human models that corticosteroid (cortisol) levels can exert both positive and negative effects on 
attention, depending on the relative occupancy of corticosteroid receptors (Lupien & McEwen 1997). 
Given the evidence of hypothalamic-pituitary-adrenal (HPA) axis dysfunction and hypercortisolaemia in 
BD (Rybakowski & Twardowska 1999; Gallagher et al. 2007), which is present in euthymia but worse in 
depression, examining the hypothesized role of systems such as the HPA axis and their potential for 
causing or exacerbating state-related effects is warranted.    
 
Due to the methodological issues outlined it remains to be established if specific features of cognitive 
processes, such as intra-individual variability in sustained attention, could be considered as cognitive 
endophenotypes. It has previously been suggested that impairment on tasks such as the CPT is more an 
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indicator of general brain dysfunction, underpinning the attentional system, than a disorder-specific 
marker (Rosvold et al. 1956; Riccio et al. 2002). Given the strong relationship that has been identified 
between IIV and white matter, it is possible that some measures of IIV or components of the RT 
distribution such as tau, are sensitive markers of general white matter integrity (Fjell et al. 2011; Jackson 
et al. 2012; Tamnes et al. 2012). These links warrant detailed exploration in future studies – especially in 
combination with focussed processing speed and attentional assessment – to ascertain the utility of 
these measures as markers of structural and functional integrity in a variety of clinical disorders in which 
white matter impairments are implicated, such as neurodegenerative and mood disorders (Sachdev et al. 
2005; Assareh et al. 2011; Poletti et al. 2015). Including assessment in individuals with genetic risk, for 
example for mood disorder, will further inform the extent to which they can be considered 
endophenotypic markers (Hasler et al. 2006). Developing understanding of the relationship between 
specific cognitive processes and their structural and functional underpinnings has clear clinical 
implications, especially in the potential use of neurocognitive function in the stratification of mood 
disorders (Insel et al. 2010).  
 
The present study has demonstrated increased RT IIV in sustained attention in mood disorders. Further 
analysis of RT distribution parameters revealed differences in the parameters affected between MDD 
and BD, and depression and euthymia in BD. These data highlight the utility of applying measures of IIV 
to characterise cognitive variability and the potential for future application in studies examining 
neurocognitive dysfunction and its underlying functional and structural brain connectivity in mood 
disorder.  
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Table 1. Demographic and clinical details 
 
 All healthy controls 
(n=138) 
BD euthymic  
(n=86) 
Control comparison a 
(n=86)  
BD depressed 
(n=33) 
Control comparison 
a (n=33) 
MDD  
(n=39) 
Control comparison a 
(n=39)  
 Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD 
Age 40.5 12.54 44.0 9.74 43.8 9.61 47.0 8.64 46.7 8.42 32.3 10.11 32.5 10.37 
NART estimated IQ 111.1 8.64 110.9 10.28 111.4 8.63 109.0 10.21 109.8 8.44 108.2 11.04 109.1 9.15 
HAMD21 - - 1.6 1.66 - - 21.9 5.75 - - 22.4 5.29 - - 
Age of onset - - 24.8 7.12 - - 25.8 13.23 - - 29.0 8.65 - - 
Bipolar I or II (n)b - - 70 BD-I, 16 BD-II - - 12 BD-I, 16 BD-II - - - - - - 
 
a Each control comparison was sampled from the overall control group (see methods)so are not independent.  
b SCID diagnosed bipolar type I or II (missing for n=5 BD depressed) 
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Table 2. Descriptive statistics for RT data and response profile 
 All healthy controls 
(n=138) 
BD euthymic  
(n=86) 
Control comparison a 
(n=86)  
BD depressed 
(n=33) 
Control comparison a 
(n=33) 
MDD  
(n=39) 
Control comparison a 
(n=39)  
 Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD 
Average RT (ms) 375.9 69.08 411.0* 75.56 382.7 71.91 412.9 96.07 390.9 80.84 382.7 88.91 378.3 87.33 
iSD 83.6 29.78 95.9* 29.93 85.4 33.34 143.8*** 56.21 80.7 29.70 104.8* 50.28 83.1 26.53 
CoV 0.23 0.08 0.24 0.07 0.23 0.09 0.36*** 0.14 0.21 0.08 0.27 0.09 0.23 0.09 
Ex-Gaussian 
parameters 
              
Mu 310.0 76.60 332.2 76.55 316.0 75.93 296.0 87.66 324.6 82.76 298.5 78.66 309.4 95.24 
Sigma b 32.1 20.82 37.7 21.19 33.2 21.78 45.2* 33.85 29. 8 18.46 40.8 39.62 31.2 17.97 
Tau 66.0 29.14 78.8* 32.55 66.8 28.98 117.3*** 59.40 66.3 22.32 84.5 47.67 68.9 28.71 
Response profile c               
Early response 0.54 1.09 0.70 1.22 0.62 1.29 3.06** 5.49 0.36 0.99 1.67 4.16 0.62 1.60 
Late response 0.36 0.93 0.45 0.84 0.44 1.12 2.55*** 2.66 0.30 0.68 0.74 1.41 0.26 0.50 
Misses  0.90 2.19 3.77** 7.05 1.01 2.65 2.79* 3.66 0.88 1.22 3.95* 6.98 0.67 0.98 
* p<0.05,   **p≤0.01,   ***p<0.0001    compared to respective control comparison data 
a Each control comparison was resampled from the overall control group (n=138) so are not independent (see methods).  
b For n=4 datasets (1.3%), sigma was returned as 0 in the ex-Gaussian model. 
c Mann-Whitney U test.  
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Figure 1.  
Title: The Vigil Continuous Performance Test 
 
Legend: Stimulus timing and example of a re-classification of a late response to a target sequence (left). 
General response classification rules (right). *If the previous stimulus was a target, the algorithm first 
checked if this target already had a valid response, in which case the current response was also classified 
as a commission error. This path is omitted in the figure. 
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Figure 2. 
Title: Vincentile plots for all clinical groups compared to matched control data 
 
Legend: V1 to V8 denotes each Vincentile (sequential 12.5% of RT data) from fastest to slowest RT. 
